# Lin Rui

Lin Rui is a senior partner at Eight Roads Capital and co-head of the China Healthcare Fund. She has led investments in leading companies in various industries such as Beijing Yingshuoli Technology (acquired by Hologic, Inc.), Haili Biotech (SH 603718), Jianyou (SH 603707), Aibo Medical (SH 688050), Gushengtang (HK 02273), Sipai Health (HK 00314) and Banger Orthopedics. Joined Eight Roads Venture Capital China team in. Bachelor's degree in Economics from Shenzhen University and MBA from the Wharton School of the University of Pennsylvania; previously worked at CMT ChinaValue Capital Partners, Vision Capital China, A.T. Kearney, and Arthur Andersen (2007).

Lin Rui is a senior partner at Eight Roads Capital and co-head of the China Healthcare Fund. She has led investments in leading companies in various industries such as Beijing Yingshuoli Technology (acquired by Hologic, Inc.), Haili Biotech (SH 603718), Jianyou (SH 603707), Aibo Medical (SH 688050), Gushengtang (HK 02273), Sipai Health (HK 00314) and Banger Orthopedics. Joined Eight Roads Venture Capital China team in. Bachelor's degree in Economics from Shenzhen University and MBA from the Wharton School of the University of Pennsylvania; previously worked at CMT ChinaValue Capital Partners, Vision Capital China, A.T. Kearney, and Arthur Andersen (2007).

Canonical: https://uniquebase.ai/people/lin-rui
Stable identifier: UB-P4107
Snapshot captured: 2026-10-22T00:48:04.883Z
English updated: 2026-10-22T03:03:47.970Z

## Sources

- No source links are available for this profile.